colforsin has been researched along with fluocinolone acetonide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colburn, NH; Dong, Z; Lavrovsky, V | 1 |
| Colburn, N; Dong, Z; Lavrovsky, V; Ma, WY | 1 |
2 other study(ies) available for colforsin and fluocinolone acetonide
| Article | Year |
|---|---|
Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors.
Topics: Animals; Anticarcinogenic Agents; Cell Transformation, Neoplastic; Cells, Cultured; Colforsin; Cyclic AMP; Drug Resistance; Fluocinolone Acetonide; Glucocorticoids; Mice; Phenotype; Sensitivity and Specificity; Skin; Skin Neoplasms; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Tretinoin | 1995 |
Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells.
Topics: 3T3 Cells; Animals; Cell Division; Cell Line; Cell Transformation, Neoplastic; Clone Cells; Colforsin; Epidermal Growth Factor; Fluocinolone Acetonide; Glucocorticoids; Mice; Phenotype; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transfection | 1996 |